自动化成瘾行为检查表识别问题性阿片类药物使用
这项横断面研究基于范德堡大学医学中心8063例慢性疼痛患者的电子健康记录,评估正则表达式自动化成瘾行为检查表识别问题性阿片类药物使用,并与人工病历审查及阿片类药物使用障碍诊断代码比较,在主要站点和盖辛格100例外部验证中,自动化方法的F1分数和曲线下面积均优于诊断代码。
要点
- 自动化方法在主要站点的F1分数为0.73(95%CI 0.62-0.83),诊断代码为0.08(95%CI 0.00-0.19)。
- 自动化方法在验证站点的F1分数为0.70(95%CI 0.50-0.85),诊断代码为0.29(95%CI 0.07-0.50)。
- 自动化方法在主要站点的曲线下面积为0.82(95%CI 0.73-0.89),诊断代码为0.52(95%CI 0.50-0.55)。
核心结论
- 这种自动化数据提取技术可能有助于更早识别有问题性阿片类药物使用风险及正在经历问题性阿片类药物使用的人群,并为研究阿片类药物疼痛管理的长期后遗症创造新机会。
研究设计与样本
- 横断面研究,报告一个回顾性队列,数据分析时间为2021年至2023年。
- 使用范德堡大学医学中心合成衍生数据库(去标识化的电子健康记录)中8063例慢性疼痛患者,慢性疼痛由至少2天的诊断代码定义。
- 在盲法人工审查的保留测试集上评估,并在另一机构的独立测试集(盖辛格介入性疼痛门诊队列的100例慢性疼痛患者)中进行外部验证。
主要发现
- 主要站点8063例患者中女性5081例(63%)、男性2982例(37%),平均(SD)年龄56(16)岁;验证站点100例患者中女性57例(57%)、男性43例(43%),平均(SD)年龄54(13)岁。
- 主要站点自动化方法F1分数为0.73(95%CI 0.62-0.83),诊断代码为0.08(95%CI 0.00-0.19)。
- 验证站点自动化方法F1分数为0.70(95%CI 0.50-0.85),诊断代码为0.29(95%CI 0.07-0.50)。
- 主要站点自动化方法曲线下面积为0.82(95%CI 0.73-0.89),诊断代码为0.52(95%CI 0.50-0.55)。
- 验证站点自动化方法曲线下面积为0.86(95%CI 0.76-0.94),诊断代码为0.59(95%CI 0.50-0.67)。
关键数值与推荐
- 主要结局为评估自动化方法识别问题性阿片类药物使用患者,并与人工病历审查及阿片类药物使用障碍诊断代码比较。
- 评估指标包括F1分数(单一阈值下结合敏感度和阳性预测值的单一值)和曲线下面积(多个阈值下结合敏感度和特异度的单一值)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Individuals whose chronic pain is managed with opioids are at high risk of developing an opioid use disorder. Electronic health records (EHR) allow large-scale studies to identify a continuum of problematic opioid use, including opioid use disorder. Traditionally, this is done through diagnostic codes, which are often unreliable and underused. OBJECTIVE: To determine whether regular expressions, an interpretable natural language processing technique, could automate a validated clinical tool (Addiction Behaviors Checklist) to identify problematic opioid use. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study reports on a retrospective cohort with data analyzed from 2021 through 2023. The approach was evaluated against a blinded, manually reviewed holdout test set and validated against an independent test set at a separate institution. The study used data from Vanderbilt University Medical Center's Synthetic Derivative, a deidentified version of the EHR for research purposes. This cohort comprised 8063 individuals with chronic pain, defined by diagnostic codes on at least 2 days. The study team collected free-text notes, demographics, and diagnostic codes and performed an external validation with 100 individuals with chronic pain from Geisinger, recruited from an interventional pain clinic cohort. MAIN OUTCOMES AND MEASURES: The primary outcome was the evaluation of the automated method in identifying patients demonstrating problematic opioid use and its comparison with manual medical record review and opioid use disorder diagnostic codes. Methods with F1 scores were evaluated (a single value that combines sensitivity and positive predictive value at a single threshold) and areas under the curve (a single value that combines sensitivity and specificity across multiple thresholds). RESULTS: Among the 8063 patients in the primary site (5081 female [63%] and 2982 male [37%]; mean [SD] age, 56 [16] years) and 100 patients in the validation site (57 female [57%] and 43 male [43%]; mean [SD] age, 54 [13] years), the automated approach outperformed diagnostic codes based on F1 scores (0.73; 95% CI, 0.62-0.83 vs 0.08; 95% CI, 0.00-0.19 at the primary site and 0.70; 95% CI, 0.50-0.85 vs 0.29; 95% CI, 0.07-0.50 at the validation site) and areas under the curve (0.82; 95% CI, 0.73-0.89 vs 0.52; 95% CI, 0.50-0.55 at the primary site and 0.86; 95% CI, 0.76-0.94 vs 0.59;95% CI, 0.50-0.67 at validation site). CONCLUSIONS: This automated data extraction technique may facilitate earlier identification of people at risk for and who are experiencing problematic opioid use, and create new opportunities for studying long-term sequelae of opioid pain management.
引用
- Chatham AH, Bradley ED, Troiani V, et al. Automating the Addiction Behaviors Checklist for Problematic Opioid Use Identification. JAMA Psychiatry. 2025. PMID: 40202749. doi:10.1001/jamapsychiatry.2025.0424
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。